{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:38:21Z","timestamp":1790818701401,"version":"4.1.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Prader-Willi syndrome (PWS, OMIM176270) is a rare genetic disorder with recognizable dysmorphic features and multisystemic consequences such as endocrine, neurocognitive and metabolic ones. Although most patients with Prader-Willi syndrome exhibit hypogonadotropic hypogonadism, there is variability regarding sexual maturation, with precocious puberty occurring in rare cases. Our aim is to elaborate a thorough review of Prader-Willi patients with central precocious puberty, in order to raise awareness of such cases and to enhance our knowledge regarding the diagnosis and prompt treatment of this particular PWS patients.<\/jats:p>","DOI":"10.3389\/fendo.2023.1150323","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T04:39:32Z","timestamp":1683520772000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Central precocious puberty in Prader-Willi syndrome: a narrative review"],"prefix":"10.3389","volume":"14","author":[{"given":"Delia-Maria","family":"Nicoar\u0103","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra-Cristina","family":"Scutca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niculina","family":"Mang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulius","family":"Juganaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei-Ioan","family":"Munteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"Vitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otilia","family":"M\u0103rginean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/473941","article-title":"Prader-willi syndrome: clinical aspects","volume":"2012","author":"Grechi","year":"2012","journal-title":"J Obes"},{"key":"B2","first-page":"1260","article-title":"Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myotonieartigem zustand im neugeborenenalter","volume":"86","author":"Prader","year":"1956","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2019.02.012","article-title":"Epigenetic therapy of prader-willi syndrome","volume":"208","author":"Kim","year":"2019","journal-title":"Transl Res"},{"key":"B4","article-title":"Chromosome 15 abnormalities and the prader-willi syndrome: a follow-up report of 40 cases","volume":"34","author":"Ledbetter","year":"1982","journal-title":"Am J Hum Genet"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM198102053040604","article-title":"Deletions of chromosome 15 as a cause of the prader-willi syndrome","volume":"304","author":"Ledbetter","year":"1981","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10245781","article-title":"Hypogonadism in women with prader-willi syndrome-clinical recommendations based on a Dutch cohort study, review of the literature and an international expert panel discussion","volume":"10","author":"Pellikaan","year":"2021","journal-title":"J Clin Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0312-9","article-title":"Prader-willi syndrome: a review of clinical, genetic, and endocrine findings","volume":"38","author":"Angulo","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1038\/342281a0","article-title":"Genetic imprinting suggested by maternal heterodisomy in nondeletion prader-willi syndrome","volume":"342","author":"Nicholls","year":"1989","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041993","article-title":"Hypogonadism in patients with prader willi syndrome: a narrative review","volume":"22","author":"Napolitano","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/life10100237","article-title":"Premature adrenarche in children with prader-willi syndrome treated with recombinant human growth hormone seems to not influence the course of central puberty and the efficacy and safety of the therapy","volume":"10","author":"Lecka-Ambroziak","year":"2020","journal-title":"Life (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000053184","article-title":"Auxological and endocrine evolution of 28 children with prader-willi syndrome: effect of GH therapy in 14 children","volume":"53","author":"Tauber","year":"2000","journal-title":"Horm Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.21037\/tp.2017.09.04","article-title":"Review of prader-willi syndrome: the endocrine approach","volume":"6","author":"Heksch","year":"2017","journal-title":"Transl Pediatr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-008-0679-0","article-title":"Central precocious puberty and growth hormone deficiency in a boy with prader-willi syndrome","volume":"167","author":"Crin\u00f2","year":"2008","journal-title":"Eur J Pediatr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0901","article-title":"Hypogonadism in females with prader-willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction","volume":"162","author":"Eldar-Geva","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B15","article-title":"Central precocious puberty in a girl with prader-willi syndrome","volume":"26","author":"Lee","year":"2013","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1530\/EDM-22-0244","article-title":"Idiopathic central precocious puberty with prader-willi syndrome: pubertal development with discontinuation of gonadotropin-releasing hormone analog","volume":"2022","author":"Kobayashi","year":"2022","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1590\/2359-3997000000196","article-title":"A boy with prader-willi syndrome: unmasking precocious puberty during growth hormone replacement therapy","volume":"60","author":"Ludwig","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4158\/ACCR-2019-0245","article-title":"Central precocious puberty in two boys with prader-willi syndrome on growth hormone treatment","volume":"5","author":"Monai","year":"2019","journal-title":"AACE Clin Case Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/080352599750030482","article-title":"Prader-Labhart-Willi syndrome with central precocious puberty and empty sella syndrome","volume":"88","author":"Linnemann","year":"1999","journal-title":"Acta Paediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1515\/JPEM.2008.21.5.495","article-title":"Treatment of precocious puberty in a female with prader-willi syndrome","volume":"21","author":"Pusz","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-002-1132-4","article-title":"Genetic obesity study group of Italian society of pediatric endocrinology and diabetology (SIEDP). Hypogonadism and pubertal development in prader-willi syndrome","volume":"162","author":"Crin\u00f2","year":"2003","journal-title":"Eur J Pediatr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2760","article-title":"Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with prader-willi syndrome","volume":"94","author":"Hirsch","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","first-page":"1","article-title":"A case of central precocious puberty in a patient with prader-willi syndrome","volume":"86","author":"Pellegrin","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"B24","first-page":"1","article-title":"Precocious puberty in a girl with prader willi syndrome","volume":"86","author":"Papagianni","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"B25","first-page":"435","article-title":"Central precocious puberty and hypobetalipoproteinaemia in a boy with prader-willi syndrome","volume":"80","author":"Karachaliou","year":"2013","journal-title":"Hormone Res Paediatrics"},{"key":"B26","first-page":"346","article-title":"Idiopathic central precocious puberty in prader-willi syndrome in Korea","volume":"88","author":"Cheon","year":"2017","journal-title":"Hormone Res Paediatrics"},{"key":"B27","first-page":"587","article-title":"Central precocious puberty in a boy with prader-willi syndrome eduring growth hormone replacement therapy","volume":"91","author":"Lu","year":"2019","journal-title":"Hormone Res Paediatrics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa306","article-title":"Insights from the genetic characterization of central precocious puberty associated with multiple anomalies","volume":"36","author":"Canton","year":"2021","journal-title":"Hum Reprod"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00380-0","article-title":"Causes, diagnosis, and treatment of central precocious puberty","volume":"4","author":"Latronico","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/jcrpe.galenos.2019.2018.0249","article-title":"Syndromic disorders caused by disturbed human imprinting","volume":"12","author":"Carli","year":"2020","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.22.1.0418","article-title":"Neurobiological mechanisms of the onset of puberty in primates","volume":"22","author":"Terasawa","year":"2001","journal-title":"Endocr Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.233","article-title":"Puberty in 2013: unravelling the mystery of puberty","volume":"10","author":"Ojeda","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1297\/cpe.2022-0021","article-title":"Genetic causes of central precocious puberty","volume":"31","author":"Tajima","year":"2022","journal-title":"Clin Pediatr Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14475","article-title":"Central precocious puberty: recent advances in understanding the aetiology and in the clinical approach","volume":"95","author":"Maione","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B35","doi-asserted-by":"crossref","first-page":"4305\u201413","DOI":"10.1210\/jc.2010-1025","article-title":"Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoptionand immigration","volume":"95","author":"Soriano-Guill\u00e9n","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","first-page":"942\u20145","article-title":"Value of basal serum gonadotropin levels in the diagnosis of precocious puberty in girls","volume":"14","author":"Liang","year":"2012","journal-title":"Zhongguo Dang Dai Er Ke ZaZhi"},{"key":"B37","first-page":"1\u20146","article-title":"Etiology of precocious puberty, 10years study in endocrine research centre (Firouzgar), Tehran","volume":"10","author":"Rohani","year":"2012","journal-title":"Iran J Reprod Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.endinu.2018.12.007","article-title":"Central precocious puberty in girls: diagnostic study and auxological response to triptorelin treatment","volume":"66","author":"Dur\u00e1-Trav\u00e9","year":"2019","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14578","article-title":"Interpretation of reproductive hormones before, during and after the pubertal transition-identifying health and disordered puberty","volume":"95","author":"Howard","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2013.04.003","article-title":"Pubertal timing and the development of psychopathology in adolescence and beyond","volume":"64","author":"Graber","year":"2013","journal-title":"Horm Behav"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/s13633-020-00090-6","article-title":"Outcomes in children treated with growth hormone for prader-willi syndrome: data from the ANSWER program\u00ae and NordiNet\u00ae international outcome study","volume":"2020","author":"Angulo","year":"2020","journal-title":"Int J Pediatr Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1159\/000313377","article-title":"French Reference centre for PWS. endocrine disorders in children with prader-willi syndrome\u2013data from 142 children of the French database","volume":"74","author":"Diene","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-820683-6.00026-9","article-title":"Prader-willi syndrome: hormone therapies","volume":"181","author":"Tauber","year":"2021","journal-title":"Handb Clin Neurol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00002-4","article-title":"Endocrine disorders in prader-willi syndrome: a model to understand and treat hypothalamic dysfunction","volume":"9","author":"Tauber","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-021-03892-5","article-title":"Management of short stature: use of growth hormone in GH-deficient and non-GH-Deficient conditions","volume":"88","author":"Vyas","year":"2021","journal-title":"Indian J Pediatr"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2142164.082","article-title":"Prader-willi syndrome: an update on obesity and endocrine problems","volume":"26","author":"Kim","year":"2021","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10143176","article-title":"On behalf of the polish coordination group for rhGH treatment. effects of recombinant human growth hormone treatment, depending on the therapy start in different nutritional phases in paediatric patients with prader-willi syndrome: a polish multicentre study","volume":"10","author":"Lecka-Ambroziak","year":"2021","journal-title":"J Clin Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2019-000630","article-title":"Growth hormone treatment in prader-willi syndrome patients: systematic review and meta-analysis","volume":"4","author":"Passone","year":"2020","journal-title":"BMJ Paediatr Open"},{"key":"B49","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2012-3888","article-title":"GrowthHormone research society workshop summary: consensus guidelines for recombinant human growth hormone therapy in prader-willi syndrome","volume":"98","author":"Deal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01541-4","article-title":"Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients","volume":"44","author":"Maciel","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B51","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3476(89)80341-5","article-title":"Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty","volume":"115","author":"Manasco","year":"1989","journal-title":"J Pediatr"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3476(05)81074-1","article-title":"Preserving adult height potential in girls with idiopathic true precocious puberty","volume":"117","author":"Kreiter","year":"1990","journal-title":"J Pediatr"},{"key":"B53","doi-asserted-by":"crossref","DOI":"10.1210\/jcem-65-6-1112","article-title":"Somatomedin-c and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion","volume":"65","author":"Rappaport","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","volume-title":"Precocious sexual development: a clinical study of 100 children","author":"Thamdrup","year":"1961"},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.1001\/archpedi.1968.02100010311003","article-title":"Precocious puberty: a report of 96 cases","volume":"115","author":"Sigurjonsdottir","year":"1968","journal-title":"Am J Dis Child"},{"key":"B56","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1986.03370190097031","article-title":"Luteinizing hormone releasing hormone analogue therapy for central precocious puberty: long-term effect on somatic growth, bone maturation, and predicted height","volume":"255","author":"Comite","year":"1986","journal-title":"JAMA"},{"key":"B57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1210\/edrv-7-1-24","article-title":"Use of a potent, long-acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty","volume":"7","author":"Boepple","year":"1986","journal-title":"Endocr Rev"},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3476(89)80806-6","article-title":"Effects of leuprolide in the treatment of central precocious puberty","volume":"114","author":"Lee","year":"1989","journal-title":"J Pediatr"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-018-0079-4","article-title":"Precocious or early puberty in patients with combined pituitary hormone deficiency due to POU1F1 gene mutation: case report and review of possible mechanisms","volume":"17","author":"Ba\u015f","year":"2018","journal-title":"Hormones (Athens)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01140-9","article-title":"POU1F1 mutations in combined pituitary hormone deficiency: differing spectrum of mutations in a Western-Indian cohort and systematic analysis of world literature","volume":"24","author":"Jadhav","year":"2021","journal-title":"Pituitary"},{"key":"B61","doi-asserted-by":"crossref","DOI":"10.1515\/JPEM.2001.14.2.215","article-title":"Two patients with kabuki syndrome presenting with endocrine problems","volume":"14","author":"Bereket","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.1159\/000184355","article-title":"Growth hormone deficiency and premature thelarche in a female infant with kabuki makeup syndrome","volume":"43","author":"Devriendt","year":"1995","journal-title":"Horm Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.6065\/apem.2016.21.1.15","article-title":"Endocrine dysfunctions in children with williams-beuren syndrome","volume":"21","author":"Kim","year":"2016","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/apa.14198","article-title":"Endocrine manifestations in children with williams-beuren syndrome","volume":"107","author":"Levy-Shraga","year":"2018","journal-title":"Acta Paediatr"},{"key":"B65","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12887-022-03474-0","article-title":"Precocious puberty or growth hormone deficiency as initial presentation in Mayer-Rokitansky-kuster-Hauser syndrome: a clinical report of 5 cases","volume":"22","author":"Ai","year":"2022","journal-title":"BMC Pediatr"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-06-0688","article-title":"GH deficiency with central precocious puberty: a new rare disorder associated with a developmental defect of the hypothalamic-pituitary area","volume":"156","author":"Ladjouze","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B67","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwm237","article-title":"Association of low age at menarche with increased all-cause mortality: a 37-year follow-up of 61,319 Norwegian women","volume":"166","author":"Jacobsen","year":"2007","journal-title":"Am J Epidemiol"},{"key":"B68","doi-asserted-by":"crossref","DOI":"10.2147\/IJWH.S158706","article-title":"Is age at menarche associated with total mortality? the tromso study","volume":"10","author":"Lundblad","year":"2018","journal-title":"Int J Womens Health"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0103","article-title":"Genetics in endocrinology: genetic etiologies of central precocious puberty and the role of imprinted genes","volume":"183","author":"Roberts","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B70","doi-asserted-by":"crossref","first-page":"823064","DOI":"10.1155\/2013\/823064","article-title":"Male Central precocious puberty: serum profile of anti-mullerian hormone and inhibin b before, during, and after treatment with GnRH analogue","volume":"2013","author":"Grinspon","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.40","article-title":"Pros and cons of GnRHa treatment for early puberty in girls","volume":"10","author":"Willemsen","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.1080\/13543784.2017.1323869","article-title":"Investigational and experimental GnRH analogs and associated neurotransmitters","volume":"26","author":"Blumenfeld","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"key":"B73","doi-asserted-by":"crossref","DOI":"10.1159\/000439337","article-title":"Therapeutic neuroendocrine agonist and antagonist analogs of hypothalamic neuropeptides as modulators of the hypothalamic-pituitary-gonadal axis","volume":"30","author":"Newton","year":"2016","journal-title":"Endocr Dev"},{"key":"B74","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2001-020243","article-title":"Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg)","volume":"87","author":"Carel","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B75","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-2704","article-title":"Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty","volume":"97","author":"Lee","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B76","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3476(05)81162-X","article-title":"Two-year results of treatment with depot leuprolide acetate for central precocious puberty","volume":"121","author":"Neely","year":"1992","journal-title":"J Pediatr"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1150323\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T11:34:17Z","timestamp":1683891257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1150323\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":76,"alternative-id":["10.3389\/fendo.2023.1150323"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1150323","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"article-number":"1150323"}}